Page last updated: 2024-11-03

propafenone and Myoclonic Jerk

propafenone has been researched along with Myoclonic Jerk in 3 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chua, TP1
Farrell, T1
Lipkin, DP1
Devoize, JL1
Flammang, D1
Marcombes, JL1
Madigand, M1
Dien, J1
Pavin, G1
Allain, H1

Other Studies

3 other studies available for propafenone and Myoclonic Jerk

ArticleYear
Myoclonus associated with propafenone.
    BMJ (Clinical research ed.), 1994, Jan-08, Volume: 308, Issue:6921

    Topics: Aged; Aged, 80 and over; Female; Humans; Myoclonus; Propafenone

1994
[Myoclonic encephalopathy probably due to propafenone].
    Presse medicale (Paris, France : 1983), 1986, Feb-22, Volume: 15, Issue:8

    Topics: Aged; Anti-Arrhythmia Agents; Female; Humans; Myoclonus; Propafenone; Propiophenones

1986
[Myoclonic encephalopathy probably attributable to propafenone].
    Presse medicale (Paris, France : 1983), 1988, Mar-26, Volume: 17, Issue:11

    Topics: Aged; Humans; Male; Myoclonus; Propafenone

1988